Advertisement
Screener

Synergy CHC Corp. (SNYR) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent

Synergy CHC Corp. Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent

Synergy CHC Corp. (SNYR) reported Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent of $22.08 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent · last filed 2026-05-14

  • Synergy CHC Corp. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2026-03-31 was $22.08K.
  • Synergy CHC Corp. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2025-09-30 was -$26.08K.
  • Synergy CHC Corp. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2025-06-30 was $39.87K, a 28.46% decline year-over-year.
  • Synergy CHC Corp. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2025-03-31 was -$1.94K, a 101.47% decline year-over-year.
  • Synergy CHC Corp. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2025 was -$106.50K, a 294.74% decline from fiscal 2024.
  • Synergy CHC Corp. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2024 was $54.69K.
  • Synergy CHC Corp. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2023 was -$124.86K.
  • Synergy CHC Corp. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2019 was -$167.75K, a 165.25% decline from fiscal 2018.
Period endOther Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 12 month
2026-03-31$22.08K
10-Q · filed 2026-05-14
2025-12-31-$106.50K
10-K · filed 2026-04-01
2025-09-30-$26.08K
10-Q · filed 2025-11-13
$13.80K
derived: sum of 2 quarters · filed 2025-11-13
$11.86K
derived: sum of 3 quarters · filed 2026-05-14
2025-06-30$39.87K
10-Q · filed 2025-11-13
$37.94K
derived: sum of 2 quarters · filed 2026-05-14
2025-03-31-$1.94K
10-Q · filed 2026-05-14
2024-12-31$54.69K
10-K · filed 2026-04-01
2024-09-30-$79.03K
10-Q · filed 2025-11-13
-$23.29K
derived: sum of 2 quarters · filed 2025-11-13
$108.35K
derived: sum of 3 quarters · filed 2025-11-13
2024-06-30$55.74K
10-Q · filed 2025-11-13
$187.37K
derived: sum of 2 quarters · filed 2025-11-13
2024-03-31$131.64K
10-Q · filed 2025-11-13
2023-12-31-$124.86K
10-K · filed 2025-03-31
2023-09-30$105.40K
10-Q · filed 2024-12-06
$186.00
derived: sum of 2 quarters · filed 2024-12-06
-$4.26K
derived: sum of 3 quarters · filed 2024-12-06
2023-06-30-$105.21K
10-Q · filed 2024-12-06
-$109.66K
derived: sum of 2 quarters · filed 2024-12-06
2023-03-31-$4.44K
10-Q · filed 2024-12-06
2020-03-31$334.49K
10-Q · filed 2020-06-29
$265.73K
derived: sum of 2 quarters · filed 2020-06-29
$312.74K
derived: sum of 3 quarters · filed 2020-06-29
$237.68K
derived: sum of 4 quarters · filed 2020-06-29
2019-12-31-$68.76K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29
-$21.75K
derived: sum of 2 quarters · filed 2020-04-29
-$96.81K
derived: sum of 3 quarters · filed 2020-04-29
-$167.75K
10-K · filed 2020-04-29
2019-09-30$47.01K
10-Q · filed 2019-11-14
-$28.05K
derived: sum of 2 quarters · filed 2019-11-14
-$98.99K
10-Q · filed 2019-11-14
$72.29K
derived: sum of 4 quarters · filed 2020-06-29
2019-06-30-$75.06K
10-Q · filed 2019-11-14
-$146.00K
10-Q · filed 2019-08-13
$25.28K
derived: sum of 3 quarters · filed 2020-06-29
$7.70K
derived: sum of 4 quarters · filed 2020-06-29
2019-03-31-$70.94K
10-Q · filed 2020-06-29
$100.34K
derived: sum of 2 quarters · filed 2020-06-29
$82.76K
derived: sum of 3 quarters · filed 2020-06-29
$125.65K
derived: sum of 4 quarters · filed 2020-06-29
2018-12-31$171.28K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29
$153.70K
derived: sum of 2 quarters · filed 2020-04-29
$196.59K
derived: sum of 3 quarters · filed 2020-04-29
$257.11K
10-K · filed 2020-04-29
2018-09-30-$17.58K
10-Q · filed 2019-11-14
$25.31K
derived: sum of 2 quarters · filed 2019-11-14
$85.83K
10-Q · filed 2019-11-14
$55.10K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$42.89K
10-Q · filed 2019-11-14
$103.40K
10-Q · filed 2019-08-13
$72.68K
derived: sum of 3 quarters · filed 2019-11-14
$38.52K
derived: sum of 4 quarters · filed 2019-11-14
2018-03-31$60.51K
10-Q · filed 2019-11-14
$29.79K
derived: sum of 2 quarters · filed 2019-11-14
-$4.37K
derived: sum of 3 quarters · filed 2019-11-14
-$27.60K
derived: sum of 4 quarters · filed 2019-11-14
2017-12-31-$30.73K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-$64.88K
derived: sum of 2 quarters · filed 2019-03-29
-$88.11K
derived: sum of 3 quarters · filed 2019-03-29
-$94.01K
10-K · filed 2019-03-29
2017-09-30-$34.15K
10-Q · filed 2018-11-13
-$57.38K
derived: sum of 2 quarters · filed 2018-11-13
-$63.28K
10-Q · filed 2018-11-13
-$51.09K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$23.23K
10-Q · filed 2018-08-14
-$29.13K
10-Q · filed 2018-08-14
-$16.94K
derived: sum of 3 quarters · filed 2018-08-14
-$14.23K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31-$5.90K
10-Q · filed 2018-05-15
$6.29K
derived: sum of 2 quarters · filed 2018-05-15
$9.00K
derived: sum of 3 quarters · filed 2018-05-15
$10.12K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$12.19K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$14.90K
derived: sum of 2 quarters · filed 2018-04-02
$16.02K
derived: sum of 3 quarters · filed 2018-04-02
$16.02K
10-K · filed 2018-04-02
2016-09-30$2.71K
10-Q · filed 2017-11-13
$3.83K
derived: sum of 2 quarters · filed 2017-11-13
$3.83K
10-Q · filed 2017-11-13
2016-06-30$1.12K
10-Q · filed 2017-08-14
$1.12K
10-Q · filed 2017-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Functional Brands Inc. (MEHA)United States$0.001B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
MANNATECH INC (MTEX)United States$0.014B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87